Free Trial

Rep. Julie Johnson Buys Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock

Walgreens Boots Alliance logo with Retail/Wholesale background

Representative Julie Johnson (D-Texas) recently bought shares of Walgreens Boots Alliance, Inc. NASDAQ: WBA. In a filing disclosed on February 12th, the Representative disclosed that they had bought between $1,001 and $15,000 in Walgreens Boots Alliance stock on January 15th. The trade occurred in the Representative's "MERRILL LYNCH TAX EFFICIENT CORE" account.

Representative Julie Johnson also recently made the following trade(s):

  • Sold $1,001 - $15,000 in shares of Dell Technologies NYSE: DELL on 1/28/2025.
  • Sold $1,001 - $15,000 in shares of PepsiCo NASDAQ: PEP on 1/28/2025.
  • Sold $1,001 - $15,000 in shares of Intuit NASDAQ: INTU on 1/28/2025.
  • Sold $1,001 - $15,000 in shares of ALLETE NYSE: ALE on 1/28/2025.
  • Sold $1,001 - $15,000 in shares of PPG Industries NYSE: PPG on 1/27/2025.
  • Purchased $1,001 - $15,000 in shares of Progressive NYSE: PGR on 1/24/2025.
  • Purchased $1,001 - $15,000 in shares of The Goldman Sachs Group NYSE: GS on 1/24/2025.
  • Sold $1,001 - $15,000 in shares of Chubb NYSE: CB on 1/24/2025.
  • Sold $1,001 - $15,000 in shares of Morgan Stanley NYSE: MS on 1/24/2025.
  • Purchased $1,001 - $15,000 in shares of Merck & Co., Inc. NYSE: MRK on 1/17/2025.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ WBA traded up $1.36 during midday trading on Tuesday, hitting $11.06. 45,308,913 shares of the company's stock traded hands, compared to its average volume of 27,456,113. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64. The stock has a market capitalization of $9.56 billion, a price-to-earnings ratio of -1.08, a price-to-earnings-growth ratio of 1.26 and a beta of 0.65. The firm has a fifty day moving average of $10.33 and a 200 day moving average of $9.71. Walgreens Boots Alliance, Inc. has a 1 year low of $8.08 and a 1 year high of $22.47.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last released its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. The business had revenue of $39.50 billion for the quarter, compared to the consensus estimate of $37.40 billion. During the same period last year, the firm earned $0.66 earnings per share. The company's quarterly revenue was up 7.6% on a year-over-year basis. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current year.

Hedge Funds Weigh In On Walgreens Boots Alliance

Hedge funds have recently bought and sold shares of the business. First Financial Corp IN grew its holdings in shares of Walgreens Boots Alliance by 49.2% in the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after purchasing an additional 885 shares during the last quarter. Golden State Wealth Management LLC bought a new stake in shares of Walgreens Boots Alliance during the fourth quarter valued at approximately $26,000. Riverview Trust Co boosted its holdings in shares of Walgreens Boots Alliance by 123.8% in the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after purchasing an additional 1,590 shares during the period. Colonial Trust Co SC grew its stake in Walgreens Boots Alliance by 79.5% in the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,297 shares in the last quarter. Finally, Venturi Wealth Management LLC purchased a new position in Walgreens Boots Alliance during the 4th quarter worth $28,000. Institutional investors own 58.59% of the company's stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the company. Evercore ISI raised their price objective on Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock an "in-line" rating in a research note on Monday, January 13th. Truist Financial lowered their price target on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Jefferies Financial Group lowered their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a "hold" rating on the stock in a research note on Wednesday, October 23rd. TD Cowen cut their price target on Walgreens Boots Alliance from $16.00 to $14.00 and set a "buy" rating for the company in a research note on Tuesday, October 22nd. Finally, Bank of America boosted their price objective on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an "underperform" rating in a research report on Monday, January 13th. Four research analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Hold" and an average price target of $13.19.

Check Out Our Latest Stock Analysis on Walgreens Boots Alliance

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas' 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027. Johnson (Democratic Party) ran for election to the U.S. House to represent Texas' 32nd Congressional District. She won in the general election on November 5, 2024. Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson's career experience includes working as an attorney.

Walgreens Boots Alliance Company Profile

(Get Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Recommended Stories

Should You Invest $1,000 in Walgreens Boots Alliance Right Now?

Before you consider Walgreens Boots Alliance, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.

While Walgreens Boots Alliance currently has a "Reduce" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines